Lurtotecan - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Antineoplastic drug owl:NamedIndividual Chemical compound Piperazine Topoisomerase inhibitor Delta-lactone
rdfs:label	Lurtotecan
owl:sameAs	dbr:Lurtotecan
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Chemical_compounds http://en.wikipedia.org/wiki/Category:Chemical_compounds_by_chemical_bond http://en.wikipedia.org/wiki/Category:Chemical_compounds_by_element http://en.wikipedia.org/wiki/Category:Chemical_compounds_by_metal_oxidation_state http://en.wikipedia.org/wiki/Category:Chemical_compounds_by_nonmetal_oxidation_state http://en.wikipedia.org/wiki/Category:Chemical_compounds_by_physiological_function http://en.wikipedia.org/wiki/Category:Chemical_compounds_by_type http://en.wikipedia.org/wiki/Category:Lists_of_chemical_compounds http://en.wikipedia.org/wiki/Category:Piperazines http://en.wikipedia.org/wiki/List_of_drugs:_Ls%E2%80%93Ly http://en.wikipedia.org/wiki/Category:Topoisomerase_inhibitors http://en.wikipedia.org/wiki/Category:Antineoplastic_drugs http://en.wikipedia.org/wiki/Category:Delta-lactones
skos:prefLabel	Lurtotecan
skos:altLabel	lurtotecan
clgo:iupacName	(8S)-8-Ethyl-8-hydroxy-15-[(4-methylpiperazin-1-yl)methyl]-2,3-dihydro-11H-[1,4]dioxino[2,3-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-9,12(8H,14H)-dione

About: clgr:Lurtotecan